Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, et al
Furthermore, emerging studies provide evidence that SGLT2-i might have an interfering effect on aldosterone/renin ratio (ARR) in patients with T2DM, due to their diuretic and sympathoinhibition effects
Both modalities affect blood flow, and their interaction requires consideration to optimize peptide delivery while maximizing anti-inflammatory benefits
Providers often use both sequentially or together, as they address different pathophysiologic drivers of hyperglycemia
To the extent that both compounds have been used in clinical settings, the available data indicate vastly different dosage recommendations, frequency of use, and routes of administration: MK-677 is taken as oral capsules, usually once daily, thanks to its relatively long half-life